Errin (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Errin drug offered from Teva Pharmaceuticals USA, Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Norethindrone |
SUBSTANCE NAME: | NORETHINDRONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2003-01-08 |
END MARKETING DATE: | 2019-03-31 |
Errin HUMAN PRESCRIPTION DRUG Details:
Item Description | Errin from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.35(mg/1) |
START MARKETING DATE: | 2003-01-08 |
END MARKETING DATE: | 2019-03-31 |
PRODUCT ID: | 0555-0344_df13aefb-57d1-43e7-8a26-fe0a28081314 |
PRODUCT NDC: | 0555-0344 |
APPLICATION NUMBER: | ANDA076225 |
Other NORETHINDRONE Pharmaceutical Manufacturers / Labelers: